Taylor Ben R
Chief Financial Officer at RXRX
- Sold, on record
- $158k
- Dollars the filings state
- Form 4 sales
- 3
- Latest Mar 17, 2026
- Form 144 notices
- 2
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- RXRXRECURSION PHARMACEUTICALS, INC.Chief Financial Officer
Sales by reason
3
Routine
0
Plan not stated
0
No plan
0
Unusual
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 144 notice RXRXNoticeDec 29, 2025 2025
Filed to sell 21,383 shares ($89k)
Taylor Ben R, Officer
10b5-1 planFirst sale on recordFiling
- 2 Form 4 sale RXRXRoutineDec 29, 2025 same day
Sold 21,383 shares at $4.18 ($89k)
Taylor Ben R, Chief Financial Officer
10b5-1 planSold 2.7% of holdings ($3.3M position)761,550 shares leftFirst sale on recordFollows a Form 144Filing
- 3 Form 144 notice RXRXNoticeFeb 18, 2026 +51 days
Filed to sell 13,426 shares ($41k)
Taylor Ben R, Officer
10b5-1 planFiling
- 4 Form 4 sale RXRXRoutineFeb 18, 2026 same day
Sold 13,426 shares at $3.08 ($41k)
Taylor Ben R, Chief Financial Officer
10b5-1 planSold 1.1% of holdings ($3.7M position)1.2M shares leftFollows a Form 144Filing
- 5 Form 4 sale RXRXRoutineMar 17, 2026 +27 days
Sold 7,956 shares at $3.39 ($27k)
Taylor Ben R, Chief Financial Officer
10b5-1 planSold 0.7% of holdings ($4M position)1.2M shares leftFiling
Every transaction
Loading transactions…
Sales and notices (5)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Mar 17, 2026 | Mar 18, 2026 | RXRX | Chief Financial Officer | Form 4 sale | 7,956 | $27k | 0.7% | Routine | SEC |
| Feb 18, 2026 | Feb 19, 2026 | RXRX | Chief Financial Officer | Form 4 sale | 13,426 | $41k | 1.1% | Routine | SEC |
| Feb 18, 2026 | Feb 18, 2026 | RXRX | Officer | Form 144 notice | 13,426 | $41k | Notice | SEC | |
| Dec 29, 2025 | Dec 30, 2025 | RXRX | Chief Financial Officer | Form 4 sale | 21,383 | $89k | 2.7% | Routine | SEC |
| Dec 29, 2025 | Dec 29, 2025 | RXRX | Officer | Form 144 notice | 21,383 | $89k | Notice | SEC |